Longevity Health Holdings, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $1.9M | $50.3K | $0 |
| Cost of Revenue | $818.1K | $6.4K | $0 |
| Gross Profit | $1.1M | $44.0K | $0 |
| Gross Margin | 57.2% | 87.4% | — |
| Operating Expenses | |||
| Research & Development | $788.9K | $1.1M | $2.5M |
| SG&A Expense | — | — | — |
| Operating Income | $-7.1M | $-5.0M | $-5.9M |
| Operating Margin | -371.6% | -9,933.8% | — |
| Interest Expense | $18.2K | $29.4K | $33.5K |
| Pretax Income | $-6.9M | $-10.7M | $-16.2M |
| Income Tax Expense | $36.3K | $-97.3K | $0 |
| Net Income | $-6.9M | $-10.4M | $-15.4M |
| Net Margin | -361.0% | -20,605.5% | — |
| EPS (Basic) | $-4.83 | $-7.28 | $-0.73 |
| EPS (Diluted) | $-4.83 | $-7.28 | $-0.73 |
| Shares Outstanding (Basic) | 1.4M | 1.4M | 22.0M |
| Shares Outstanding (Diluted) | 1.4M | 1.4M | 22.0M |
| Dividends Per Share | — | — | — |